| Recent PTGX Stock Price | PTGX Stock Predictions | |
| $102.18 | ![]() +14.73% |
$117.23 |
| Recent PTGX Analyst Ratings Breakdown, Making PTGX Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 12 | 12 | 12 | 12 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 2 | 2 | 2 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.29 | 1.29 | 1.29 | 1.29 |
For the PTGX stock predictions from the analysts covering Protagonist Therapeutics Inc, we have collected all of the individual PTGX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 13 different analysts covering PTGX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since PTGX stock predictions may vary widely, another useful metric to consider is the median PTGX stock prediction, which represents the price at which half of the analysts
made PTGX stock predictions that were higher and half made PTGX stock predictions that were lower. This makes for a different take on the PTGX stock predictions out there, as compared to average or mean.
And that median across all the individual PTGX stock predictions was: $117.0 as of 2026-05-18.
The very highest of the PTGX stock predictions for one year price target was $137.0, while the very lowest of the PTGX stock predictions in the analyst group was
$100.0 (with a standard deviation of $9.283). Get the latest Zacks research report on PTGX — FREE
Find out: PTGX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• APO Stock Predictions
• NDSN Stock Predictions
• HCAT Stock Predictions
• AGM Stock Predictions
• GDEN Stock Predictions
• IMTX Stock Predictions
• GALT Stock Predictions
• MNSB Stock Predictions
• VVNT Stock Predictions
|
|||||||||
|
Quotes delayed 20 minutes
|
Strong Buy (3.71 out of 4) 94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |